000 01630 a2200493 4500
005 20250516072143.0
264 0 _c20130703
008 201307s 0 0 eng d
022 _a1399-0004
024 7 _a10.1111/j.1399-0004.2011.01764.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBertola, D R
245 0 0 _aMultiple, diffuse schwannomas in a RASopathy phenotype patient with germline KRAS mutation: a causal relationship?
_h[electronic resource]
260 _bClinical genetics
_cJun 2012
300 _a595-7 p.
_bdigital
500 _aPublication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't
650 0 4 _aChild
650 0 4 _aChromosomal Proteins, Non-Histone
_xgenetics
650 0 4 _aDNA-Binding Proteins
_xgenetics
650 0 4 _aFemale
650 0 4 _aGerm-Line Mutation
650 0 4 _aHumans
650 0 4 _aNeurilemmoma
_xgenetics
650 0 4 _aNeurofibromin 2
_xgenetics
650 0 4 _aPhenotype
650 0 4 _aProto-Oncogene Proteins
_xgenetics
650 0 4 _aProto-Oncogene Proteins p21(ras)
650 0 4 _aSMARCB1 Protein
650 0 4 _aTranscription Factors
_xgenetics
650 0 4 _aYoung Adult
650 0 4 _aras Proteins
_xgenetics
700 1 _aPereira, A C
700 1 _aBrasil, A C
700 1 _aSuzuki, L
700 1 _aLeite, C
700 1 _aFalzoni, R
700 1 _aTannuri, U
700 1 _aPoplawski, A B
700 1 _aJanowski, K M
700 1 _aKim, C A
700 1 _aMessiaen, L M
773 0 _tClinical genetics
_gvol. 81
_gno. 6
_gp. 595-7
856 4 0 _uhttps://doi.org/10.1111/j.1399-0004.2011.01764.x
_zAvailable from publisher's website
999 _c21430332
_d21430332